help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bjorklund, A.
Right arrow Articles by Grill, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bjorklund, A.
Right arrow Articles by Grill, V.

Endocrinology, Vol 132, 1319-1328, Copyright © 1993 by Endocrine Society


ARTICLES

B-cell insensitivity in vitro: reversal by diazoxide entails more than one event in stimulus-secretion coupling

A Bjorklund and V Grill
Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden.

Sustained hyperglycemia desensitizes pancreatic B-cells to glucose. Infusion of diazoxide protects against this effect, i.e. an insulin response to glucose is preserved after exposure to the drug in vivo. The mechanisms behind this aftereffect were presently investigated in vitro. In one type of experiment, rat pancreatic islets were exposed to diazoxide (75 micrograms/ml) for 20-22 h in tissue culture. Previous exposure to diazoxide increased 2.4-fold the response to 16.7 mM glucose in final batch-type incubations. This effect was not altered by adding insulin (10 mU/ml) to the tissue culture medium. In other experiments, islets were perifused for 180 min with 27 mM glucose and, usually, 0.2 mM 3-isobutyl-1-methylxanthine. A second stimulation, 30 min long, was used to assess desensitization, which ranged between 52- 80%. Diazoxide treatment during the first stimulation profoundly inhibited secretion and, as an aftereffect, completely prevented restimulation-assessed desensitization. Neither desensitization nor aftereffect were seen after low (6 mM) glucose treatment. Previous diazoxide treatment enhanced the response not only to glucose but also to 2.5 mM barium or 10 mM arginine. Desensitization induced by 30 mM potassium was not affected by diazoxide. Cooling (22 C) was employed to block glucose-induced exocytosis of insulin, but not proximal events in stimulus secretion coupling. Diazoxide treatment during cooling exerted an aftereffect that was attenuated, but not abolished (1.7-fold of the control, as assessed by restimulation at 37 C). When calcium was omitted from the perifusion medium during cooling, no aftereffect of diazoxide was seen. The results indicate that modulation of ATP- sensitive potassium channel activity is not closely linked to induction and expression of diazoxide's aftereffect, and furthermore, that protection from desensitization includes both proximal and distal events in stimulus-secretion coupling.


This article has been cited by other articles:


Home page
DiabetesHome page
Z. Ma, N. Portwood, D. Brodin, V. Grill, and A. Bjorklund
Effects of Diazoxide on Gene Expression in Rat Pancreatic Islets Are Largely Linked to Elevated Glucose and Potentially Serve to Enhance {beta}-Cell Sensitivity
Diabetes, April 1, 2007; 56(4): 1095 - 1106.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Yamazaki, K. C. Zawalich, and W. S. Zawalich
Desensitization of the pancreatic beta-cell: effects of sustained physiological hyperglycemia and potassium
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): H1381 - H1387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Yamazaki, W. Philbrick, K. C. Zawalich, and W. S. Zawalich
Acute and chronic effects of glucose and carbachol on insulin secretion and phospholipase C activation: studies with diazoxide and atropine
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E26 - E33.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
M. Zdravkovic, M. Kruse, K. L. Rost, J. Moss, A. Kecskes, and T. Dyrberg
The Effects of NN414, a SUR1/Kir6.2 Selective Potassium Channel Opener, in Healthy Male Subjects
J. Clin. Pharmacol., July 1, 2005; 45(7): 763 - 772.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Yoshikawa, Z. Ma, A. Bjorklund, and V. Grill
Short-term intermittent exposure to diazoxide improves functional performance of {beta}-cells in a high-glucose environment
Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1202 - E1208.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. S. Zawalich, M. Bonnet-Eymard, and K. C. Zawalich
Glucose-induced desensitization of the pancreatic beta -cell is species dependent
Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E917 - E924.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society